Director's Dealing
14 December 2010
Deltex Medical Group plc ("Deltex Medical" or the "Company"), the global leader in oesophageal Doppler monitoring ("ODM"), has been notified that on 10 December 2010 Paul Mitchell, Finance Director, disposed of 82,131 ordinary shares of one penny each in the Company at 18.0 pence per share.
As a result of the above transaction, undertaken in order to settle tax liabilities primarily relating to the exercise of options, Mr Mitchell now owns 122,350 ordinary shares, representing 0.093% of the Company's issued share capital.
Deltex Medical Group plc 01243 774 837
Nigel Keen, Chairman
Ewan Phillips, Chief Executive
Paul Mitchell, Finance Director
Nominated Adviser and Broker 0207 614 5917
Arden Partners plc
Christopher Hardie
Jamie Cameron